Data protection Impressum

R&D

Takeda will receive an exclusive option to license AC Immune's ACI-24.060, a breakthrough therapy to combat the progression of Alzheimer's disease, for an upfront payment of USD 100 million and potential milestone payments of USD 2.1 billion.

AC Immune and Takeda sign USD 100 million deal to treat Alzheimer’s disease

13 May 2024

Risklick, a spin-off from the University of Bern, has unveiled its cutting-edge software, Protocol AI, designed to transform the landscape of pharmaceutical development.

UniBe spin-off Risklick unveils AI tool to streamline clinical trials

29 April 2024

Researchers at the EPFL have engineered lab-grown mini-colons that replicate the development of colorectal tumors with high fidelity.

EPFL scientists create lab-grown mini-colons to advance colorectal cancer research

29 April 2024

The newly released Swiss Biotech Report 2024 highlights an exceptional year for the Swiss biotech industry, marking a record CHF 7.3 billion in revenues and over CHF 2 billion in capital investments.

The Swiss biotech industry: reliable partners beyond borders

23 April 2024

Sitem Startup Club (SSC) has officialized a partnership with CSEM, uniting Bern's medtech ecosystem with engineering excellence for transformative healthcare solutions.

Sitem Startup Club and CSEM forge a strategic partnership to propel medtech innovation

8 April 2024

Top Stories Western Switzerland

Business environment

Top Stories from Western Switzerland (March 2024)

26 March 2024

This funding follows closely on the heels of the completion of enrollment of Spineart’s BAGUERA® C Intervertebral Disc (IDE) studies, which aim to push the boundaries of spinal surgery through extensive research and development efforts.

Spineart raises CHF 20 million to push the boundaries of spinal surgery

20 March 2024

The project, "La Pendule," conceptualized by Losinger Marazzi SA and IPAS Architects, has been selected for its emblematic representation of innovation, standing as the final piece in the puzzle of Neuchâtel’s innovative ecosystem.

Neuchâtel’s innovation hub expands with groundbreaking JD7 building

12 March 2024

CSEM and ClexBio, a Nordic startup specializing in regenerative medicine, has developed a novel bioreactor capable of cultivating human veins in the laboratory.

CSEM and ClexBio unveil groundbreaking bioreactor to advance cardiovascular treatment

26 February 2024

This alliance between Atinary and Takeda is a shining example of how technology and healthcare can come together to create innovative solutions that address pressing challenges in drug development.

Atinary and Takeda forge a strategic alliance to advance healthcare innovation

19 February 2024

1 2 3 4 5 6 7 8 … 12